Abstract

BackgroundWhole genome sequencing has revolutionised the interrogation of mycobacterial genomes. Recent studies have reported conflicting findings on the genomic stability of Mycobacterium tuberculosis during the evolution of drug resistance. In an age where whole genome sequencing is increasingly relied upon for defining the structure of bacterial genomes, it is important to investigate the reliability of next generation sequencing to identify clonal variants present in a minor percentage of the population. This study aimed to define a reliable cut-off for identification of low frequency sequence variants and to subsequently investigate genetic heterogeneity and the evolution of drug resistance in M. tuberculosis. MethodsGenomic DNA was isolated from single colonies from 14 rifampicin mono-resistant M. tuberculosis isolates, as well as the primary cultures and follow up MDR cultures from two of these patients. The whole genomes of the M. tuberculosis isolates were sequenced using either the Illumina MiSeq or Illumina HiSeq platforms. Sequences were analysed with an in-house pipeline.ResultsUsing next-generation sequencing in combination with Sanger sequencing and statistical analysis we defined a read frequency cut-off of 30 % to identify low frequency M. tuberculosis variants with high confidence. Using this cut-off we demonstrated a high rate of genetic diversity between single colonies isolated from one population, showing that by using the current sequencing technology, single colonies are not a true reflection of the genetic diversity within a whole population and vice versa. We further showed that numerous heterogeneous variants emerge and then disappear during the evolution of isoniazid resistance within individual patients. Our findings allowed us to formulate a model for the selective bottleneck which occurs during the course of infection, acting as a genomic purification event.ConclusionsOur study demonstrated true levels of genetic diversity within an M. tuberculosis population and showed that genetic diversity may be re-defined when a selective pressure, such as drug exposure, is imposed on M. tuberculosis populations during the course of infection. This suggests that the genome of M. tuberculosis is more dynamic than previously thought, suggesting preparedness to respond to a changing environment.Electronic supplementary materialThe online version of this article (doi:10.1186/s12864-015-2067-2) contains supplementary material, which is available to authorized users.

Highlights

  • Whole genome sequencing has revolutionised the interrogation of mycobacterial genomes

  • IS6110 genotyping and spoligotyping revealed that the rifampicin mono-resistant isolates originated from different genetic backgrounds (LCC, Haarlem, Beijing and East Africa Indian 7 (EAI)), representing the broad strain diversity circulating in the Western Cape, South Africa

  • Using our cut-off of 30 % variant frequency we investigated the genomic heterogeneity within and between individual single colonies isolated from rifampicin mono-resistant M. tuberculosis clinical isolates

Read more

Summary

Introduction

Whole genome sequencing has revolutionised the interrogation of mycobacterial genomes. This study aimed to define a reliable cut-off for identification of low frequency sequence variants and to subsequently investigate genetic heterogeneity and the evolution of drug resistance in M. tuberculosis. Whole genome sequencing (WGS) has revolutionised the detailed interrogation of mycobacterial genomes at base-pair resolution. Application of this technology has provided novel insights into the evolution of members of the Mycobacterium tuberculosis complex [1,2,3]. Various studies have demonstrated the acquisition of known resistance conferring mutations in the M. tuberculosis genome during the course of infection and subsequent drug treatment. The presence of drug resistant sub-populations is a major concern when considering the variable sensitivity of standard genetic and microbiological tests for the diagnosis of drug resistance M. tuberculosis [16]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.